CONE · Cyrusone Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.03B | $981.30M | $529.10M | $672.00M | $529.10M |
| Cost of Revenue | $531.10M | $411.60M | $383.40M | $187.50M | - | - |
| Gross Profit | $674.60M | $621.90M | $597.90M | $341.60M | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $101.90M | $99.30M | $83.50M | $80.60M | $67.00M | $60.70M |
| Total Operating Expenses | $1.17B | $993.40M | $914.30M | $731.70M | $647.90M | $458.60M |
| D&A | $499.20M | $449.40M | $417.70M | $334.10M | $183.90M | $183.90M |
| Operating Income | $39.30M | $40.10M | $67.00M | $89.70M | $24.10M | $70.50M |
| Interest Expense | $64.60M | $57.70M | $82.00M | $94.70M | $68.10M | $48.80M |
| Income Tax | ($4.90M) | ($3.60M) | ($3.70M) | $600.0K | $3.00M | $1.80M |
| Net Income | $25.30M | $41.40M | $41.40M | $1.20M | ($83.50M) | $19.90M |
| EPS - Basic | $0.20 | $0.35 | $0.36 | $0.00 | ($0.95) | $0.24 |
| EPS - Diluted | $0.20 | $0.35 | $0.36 | $0.00 | ($0.95) | $0.24 |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $346.30M | $271.40M | $76.40M | $64.40M | $151.90M | $14.60M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $7.45B | $6.90B | $6.14B | $5.59B | $4.31B | $2.85B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $3.49B | $3.41B | $2.89B | $2.62B | $2.09B | $1.24B |
| Total Liabilities | $4.53B | $4.34B | $3.71B | $3.37B | $2.60B | $1.69B |
| Stockholders' Equity | $2.92B | $2.56B | $2.43B | $2.23B | $1.71B | $1.16B |
| Retained Earnings | ($1.20B) | ($966.60M) | ($767.30M) | ($600.20M) | ($486.90M) | ($249.80M) |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $477.60M | $456.30M | $365.70M | $309.30M | $289.50M | $180.60M |
| Investing Cash Flow | ($875.60M) | ($772.40M) | ($679.90M) | ($1.34B) | ($1.51B) | ($729.60M) |
| Financing Cash Flow | $487.90M | $507.20M | $324.80M | $944.70M | $1.35B | $549.30M |
| CapEx | - | - | - | $182.30M | $20.20M | - |
| Free Cash Flow | - | - | - | $127.00M | $269.30M | - |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 56.0% | 60.2% | 60.9% | 64.6% | - | - |
| Operating margin | 3.3% | 3.9% | 6.8% | 17.0% | 3.6% | 13.3% |
| EBITDA margin | 44.7% | 47.4% | 49.4% | 80.1% | 31.0% | 48.1% |
| Net margin | 2.1% | 4.0% | 4.2% | 0.2% | -12.4% | 3.8% |
| Free cash flow margin | - | - | - | 24.0% | 40.1% | - |
| FCF / Net income | - | - | - | 105.83 | -3.23 | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 8.5% | 9.6% | 8.5% | 15.2% | 10.0% | 11.5% |
| Effective tax rate | -24.0% | -9.5% | -9.8% | 33.3% | - | 8.3% |
| Return on assets | 0.3% | 0.6% | 0.7% | 0.0% | -1.9% | 0.7% |
| Return on equity | 0.9% | 1.6% | 1.7% | 0.1% | -4.9% | 1.7% |
| Return on invested capital | 0.6% | 0.7% | 1.3% | 1.2% | 0.5% | 2.7% |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 1.19 | 1.33 | 1.19 | 1.18 | 1.22 | 1.07 |
| Debt / Assets | 0.47 | 0.49 | 0.47 | 0.47 | 0.48 | 0.43 |
| Debt / EBITDA | 6.49 | 6.96 | 5.96 | 6.19 | 10.05 | 4.87 |
| Interest coverage | 0.6x | 0.7x | 0.8x | 0.9x | 0.4x | 1.4x |
| Equity multiplier | 2.55 | 2.70 | 2.52 | 2.51 | 2.52 | 2.45 |
| Liabilities / Assets | 0.61 | 0.63 | 0.60 | 0.60 | 0.60 | 0.59 |
| Efficiency | ||||||
| Asset turnover | 0.16 | 0.15 | 0.16 | 0.09 | 0.16 | 0.19 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 16.7% | 5.3% | 85.5% | -21.3% | 27.0% | 32.5% |
| Revenue CAGR (3y) | 31.6% | 15.4% | 22.9% | 9.8% | 36.6% | - |
| Revenue CAGR (5y) | 17.9% | 20.9% | 30.1% | - | - | - |
| Gross profit growth (YoY) | 8.5% | 4.0% | 75.0% | - | - | - |
| Operating income growth (YoY) | -2.0% | -40.1% | -25.3% | 272.2% | -65.8% | 209.2% |
| Net income growth (YoY) | -38.9% | 0.0% | 3350.0% | - | - | - |
| EPS growth (YoY) | -42.9% | -2.8% | - | - | - | - |
| EPS CAGR (3y) | - | - | 14.5% | - | - | - |
| EPS CAGR (5y) | -3.6% | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | -52.8% | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 14.3% | 5.1% | 9.4% | 29.9% | 47.5% | 41.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$2.43B totalLease Revenue$1.18B · 48.8%
Colocation Lease Revenue$924.10M · 38.1%
Tenant Reimbursements$259.00M · 10.7%
Other Customer Contract Revenue$22.60M · 0.9%
Other Services$18.40M · 0.8%
Contracts With Customers$15.10M · 0.6%
Equipment Sales$4.20M · 0.2%
Geographic
$400.0K totalNon Us$400.0K · 100.0%
Stability scores
Piotroski F-score
FY 2021 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- -Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing CyrusOne Inc. against the 5 most active filers in the same SIC group.